Essilor Stellest glasses: FDA-approved lens aim to slow myopia progression - Takeaways - MDSpire

FDA-Approved Essilor Stellest Lenses Designed to Mitigate Myopia Progression

By
Matthew Perrone
December 1, 2025

Associated Press Health

Share

1

The FDA approved Essilor Stellest lenses to slow myopia progression in children aged 6 to 12, promising better long-term vision outcomes.
2

Studies indicate that children using Stellest lenses experienced a 70% reduction in myopia progression over two years.
3

The lenses utilize concentric rings to refocus light, potentially preventing eye elongation and associated risks like retinal detachment.
4

The suggested retail price for Stellest lenses is $450, with major vision insurance expected to cover eligible children.
5

While no serious side effects were reported, some children experienced visual disturbances, prompting calls for further U.S. research.

Original Source(s)

Associated Press Health

Essilor Stellest glasses: FDA-approved lens aim to slow myopia progression

by Matthew Perrone
December 1, 2025

Related Content

MDSpire News

DIMS Lenses May Slow Myopia Progression

A nearly decade-long observational follow-up found continued slowing of axial elongation into late adolescence, while refractive outcomes remained less consistent.